Literature DB >> 2071124

Vaginal antibody of patients with trichomoniasis is to a prominent surface immunogen of Trichomonas vaginalis.

J F Alderete1, E Newton, C Dennis, J Engbring, K A Neale.   

Abstract

Twenty vaginal washes (VWs) and ten vaginal mucus (VM) samples from patients with trichomoniasis were examined for the presence of antibody to surface protein immunogens of Trichomonas vaginalis. Fourteen of 20 VWs (70%) and 8 of 10 VM (80%) had immunoglobulin G (IgG) antibody (Ab) that reacted in an immunoprecipitation (IP) assay with one iodinated Trichomonas vaginalis surface protein immunogen with a relative molecular mass of 230,000 daltons (230-kDa) (P230). No similar IP of any iodinated protein was observed when detergent extract was first depleted of P230 with monoclonal antibody (MAb), indicating a highly specific VW IgG response of patients to P230. VWs were also obtained from 10 patients from one to four weeks after treatment. These VWs had the same, or in one case a greater, level of IgG to P230. Under no circumstances was Ab to P230 or any other trichomonad protein detected in VWs or VM from normal, uninfected women. Flow cytofluorometry with VW Ab yielded heterogeneous fluorescent and non-fluorescent populations of trichomonads, reaffirming the restricted Ab response to one or a few epitopes on P230 in the vagina of patients. Under identical conditions, the MAb gave totally fluorescent parasite populations of some isolates, and the MAb again demonstrated variable epitope accessibility to Ab binding (Infect Immun 1987;55:1037). Finally, the MAb or VW Ab was never cytolytic for immunoreactive (fluorescent) parasites, even in the presence of complement. This study identifies the most important trichomonad surface immunogen on the basis of the vaginal Ab response, and data underscore the significance of immune evasion strategies of this sexually transmitted disease agent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071124      PMCID: PMC1194676          DOI: 10.1136/sti.67.3.220

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  12 in total

Review 1.  Trichomoniasis, candidiasis, and the minor venereal diseases.

Authors:  M F Rein; T A Chapel
Journal:  Clin Obstet Gynecol       Date:  1975-03       Impact factor: 2.190

2.  The establishment of various trichomonads of animals and man in axenic cultures.

Authors:  L S DIAMOND
Journal:  J Parasitol       Date:  1957-08       Impact factor: 1.276

3.  Relatedness of structures of a major immunogen in Trichomonas vaginalis isolates.

Authors:  J F Alderete; K A Neale
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Specific parasitism of purified vaginal epithelial cells by Trichomonas vaginalis.

Authors:  J F Alderete; P Demeś; A Gombosova; M Valent; M Fabusová; A Jánoska; J Stefanovic; R Arroyo
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.

Authors:  J F Alderete
Journal:  Br J Vener Dis       Date:  1984-06

6.  Antibody to Trichomonas vaginalis in human cervicovaginal secretions.

Authors:  K E Su
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.

Authors:  D A Street; D Taylor-Robinson; J P Ackers; N F Hanna; A McMillan
Journal:  Br J Vener Dis       Date:  1982-10

8.  Monoclonal antibody to a major surface glycoprotein immunogen differentiates isolates and subpopulations of Trichomonas vaginalis.

Authors:  J F Alderete; L Suprun-Brown; L Kasmala
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

9.  Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis.

Authors:  J F Alderete; L Kasmala
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

10.  Phenotypes and protein-epitope phenotypic variation among fresh isolates of Trichomonas vaginalis.

Authors:  J F Alderete; P Demĕs; A Gombosová; M Valent; A Yánoska; H Fabusová; L Kasmala; G E Garza; E C Metcalfe
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more
  9 in total

Review 1.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Epitopes of the highly immunogenic Trichomonas vaginalis α-actinin are serodiagnostic targets for both women and men.

Authors:  Calvin J Neace; J F Alderete
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

4.  The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65.

Authors:  Ashwini S Kucknoor; Vasanthakrishna Mundodi; John F Alderete
Journal:  Cell Microbiol       Date:  2007-06-21       Impact factor: 3.715

5.  The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases.

Authors:  J F Alderete; E Newton; C Dennis; K A Neale
Journal:  Genitourin Med       Date:  1991-12

6.  Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases.

Authors:  J F Alderete; E Newton; C Dennis; K A Neale
Journal:  Genitourin Med       Date:  1991-08

7.  Identification, characterization, and synthesis of peptide epitopes and a recombinant six-epitope protein for Trichomonas vaginalis serodiagnosis.

Authors:  J F Alderete; Calvin J Neace
Journal:  Immunotargets Ther       Date:  2013-08-12

8.  Epitopes within recombinant α-actinin protein is serodiagnostic target for Trichomonas vaginalis sexually transmitted infections.

Authors:  J F Alderete
Journal:  Heliyon       Date:  2017-01-30

9.  Advancing Prevention of STIs by Developing Specific Serodiagnostic Targets: Trichomonas vginalis as a Model.

Authors:  John F Alderete
Journal:  Int J Environ Res Public Health       Date:  2020-08-10       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.